At first, Krista Easom figured the little red bump on her foot was nothing more than a blister.
It didn’t hurt, but after a couple months, it didn’t go away either.
She booked an appointment with a dermatologist to have it removed. She wasn’t worried. Easom, a 24-year-old law school student from New Jersey, was healthy, had no family history of cancer and was getting ready to enjoy some time in her newly adopted city of Chicago.
That’s when she received the results from her dermatologist, who removed a part of the blister and had it tested.
It turns out that little red bump was malignant melanoma, the leading cause of skin cancer death in the United States. It’s a cancer that kills one person every hour, which translates to more than 8,700 Americans each year.
Further tests revealed that Easom’s melanoma had spread to her lymph nodes, which meant she needed a lymphadenectomy to have them removed. This major surgery includes a five-day stay in the hospital followed by an extensive recovery. About half of the patients who undergo this procedure suffer from wound infections because of the 12-inch incision’s hip-to-thigh location.
Easom and her family looked into her options and she was referred to Northwestern Medicine® surgical oncologists Jeffery D. Wayne, MD and Karl Bilimoria, MD, two of the very few surgeons in the country using a minimally invasive procedure to remove groin lymph nodes. This laparoscopic procedure may drastically reduce the recovery rate and chance of infection for patients like Easom.
“Only a handful of surgeons in the country are doing this and it makes a world of difference to the patient,” said Bilimoria, a surgical oncologist at Northwestern Memorial Hospital and an assistant professor of surgery at Northwestern University Feinberg School of Medicine. “Instead of a 12-inch scar, this laparoscopic procedure has only three very small incisions that total less than one inch. Because these incisions are so small, the chance of infection is far less. Instead of a five-day stay in the hospital, Krista went home the day after her surgery.”
Lymph nodes are the most frequent site of the spread of metastatic melanoma and surgically removing them is the only potential for a cure, Wayne said.
“Surgery is the only way to make sure we get all of the cancer,” Wayne said. “We want Krista to move on with her life. The minimally-invasive procedure was by far, the quickest and safest way for her to do that.”
Just a few weeks post-surgery, Easom is already on her way. She will have regular check-ups for awhile but her CT scans and blood tests show that the surgery successfully removed all of her cancer. Easom is participating in a national clinical trial to see if this minimally invasive procedure can help other melanoma patients.
The Latest on: Melanoma
- Melanoma detection on December 4, 2018 at 6:58 am
Melanoma is a type of skin cancer, it is the most lethal of the various forms of this disease. It can be cured but only if detected early enough in its progress. Now, writing in the International ... […]
- Laurence Fishburne Hosts an Upcoming "Information Matrix" Segment that Discusses Melanoma on December 4, 2018 at 12:40 am
WEST PALM BEACH, Fla., Dec. 4, 2018 /PRNewswire-PRWeb/ -- Respected actor Lawrence Fishburne hosts "Information Matrix", an educational series that covers topics that impact the modern world and appea... […]
- New drug combination could kill melanoma cells more effectively, study shows on December 3, 2018 at 7:31 pm
A class of cancer drugs called protein kinase inhibitors is one of the most effective treatments for melanoma. However, in many cases, tumors eventually become resistant to the drugs and cause a relap... […]
- New drug combination could be more effective against melanoma on December 3, 2018 at 9:35 am
MIT researchers are developing ribonucleases as potential drugs to treat cancer. In a new study, they found that the drugs work better when given with already-approved drugs known as kinase ... […]
- Michelson Diagnostics: Imaging Reveals Changes in Blood Vessel Growth in Deadly Melanoma Skin Cancer on December 2, 2018 at 11:00 pm
LONDON, December 3, 2018 /PRNewswire via COMTEX/ -- LONDON, December 3, 2018 /PRNewswire/ -- A new clinical study has shown that Dynamic Optical Coherence Tomography imaging of melanomas (D-OCT) revea... […]
- Completion Lymph Node Dissection in Melanoma on December 2, 2018 at 4:24 pm
Axel Hauschild, MD: The question is, what do we do with patients if the sentinel node is positive? Do we need a completion lymphadenectomy? I guess it’s very important to emphasize that the patients w... […]
- BMS flips negative NICE ruling on Opdivo, winning thumbs-up for preventing melanoma relapse on November 30, 2018 at 6:37 am
In September, Britain’s drug-cost watchdog, The National Institute for Health and Care Excellence (NICE), said Bristol-Myers Squibb did not make a convincing enough case that PD-1 blocker Opdivo shoul... […]
- Management of Locally Advanced Melanoma on November 29, 2018 at 5:08 pm
Axel Hauschild, MD: Hello, and welcome to this OncLive Peer Exchange ® panel discussion, which will explore treatment advances for metastatic melanoma. The tools we have available for treating patient... […]
- Eye Melanoma Market Robust Expansion by Top Key Manufactures, Demand and Supply to 2023 on November 27, 2018 at 4:11 am
Melanoma is the cancer of melanin-producing cells. Eye melanoma or ocular melanoma can develop in the middle of the three layers of the eye, i.e., in between the sclera, retina, and uvea. The diseased ... […]
- Using molecular targeting approach to kill melanoma cells on November 26, 2018 at 11:10 pm
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this ... […]
via Google News and Bing News